Comment on "Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases".

Xueting Li,Lei Liu

DOI: https://doi.org/10.1002/jso.27451

2023-01-01

Journal of Surgical Oncology

Abstract:Journal of Surgical OncologyEarly View LETTER TO THE EDITOR Comment on “Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases” Xueting Li, Xueting Li Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China Department of Oncology, 363 Hospital, Chengdu, ChinaSearch for more papers by this authorLei Liu, Corresponding Author Lei Liu [email protected] Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China Correspondence Lei liu, Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Email: [email protected]Search for more papers by this author Xueting Li, Xueting Li Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China Department of Oncology, 363 Hospital, Chengdu, ChinaSearch for more papers by this authorLei Liu, Corresponding Author Lei Liu [email protected] Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China Correspondence Lei liu, Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Email: [email protected]Search for more papers by this author First published: 11 October 2023 https://doi.org/10.1002/jso.27451Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Chen Q, Li K, Rhodin KE, et al. Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases. J Surg Oncol. 2023; 127: 945-955. 2Alese OB, Jiang R, Shaib W, et al. High-grade gastrointestinal neuroendocrine carcinoma management and outcomes: a national cancer database study. Oncologist. 2019; 24: 911-920. 3Miller L, Jones A, Anderson R. Challenges in rare disease research: methodological considerations. Rare Dis J. 2022; 10(3): 203-210. 4Brown H, Thompson W. Randomized controlled trials in oncology: best practices and current challenges. J Cancer Res Clin Oncol. 2021; 147(1): 25-34. 5Smith J, Thomas R, Lee H. Personalized treatments in cancer care: a review. J Clin Oncol. 2021; 39(5): 501-510. 6Johnson M, Collins L. The importance of national databases in medical research. Health Informatics J, 2020; 26(2): 120-128. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation